UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Painless Drug Delivery Through Microneedle-Based Transdermal Patches Featuring Active Infusion

IEEE transactions on biomedical engineering, 2008-03, Vol.55 (3), p.1063-1071

2008

Volltextzugriff (PDF)

Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases

Annals of oncology, 2017-10, Vol.28 (10), p.2464-2471

2017

Volltextzugriff (PDF)

Final results from a phase i clinical trial evaluating the safety, immunogenicity, and anti-tumor activity of SNS-301 in men with biochemically relapsed prostate cancer

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii136

2018

Volltextzugriff (PDF)

Synthetic DNA immunotherapy in biochemically relapsed prostate cancer

Annals of oncology, 2018-10, Vol.29, p.viii290-viii290

2018

Volltextzugriff (PDF)

177Lu-PSMA-617 dans le cancer de la prostate métastatique résistant à la castration PSMA positif : analyse des traitements antérieurs et concomitants – VISION

Médecine nucléaire : imagerie fonctionelle et métabolique, 2023-03, Vol.47 (2), p.55-55

2023

Volltextzugriff (PDF)

[177Lu]Lu-PSMA-617 dans le cancer de la prostate métastatique positif au PSMA et résistant à la castration : analyses des sous-groupes de traitement antérieurs et concomitants de l’essai vision

Progrès en urologie. Formation médicale continue, 2022-11, Vol.32 (3), p.S4-S5

2022

Volltextzugriff (PDF)

A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide

ESMO open, 2021-04, Vol.6 (2), p.100082-100082, Article 100082

2021

Volltextzugriff (PDF)

4 Activity of galeterone in castrate-resistant prostate cancer (CRPC) with C-terminal AR loss: Results from ARMOR2

European journal of cancer (1990), 2014-11, Vol.50, p.8-8

2014

Volltextzugriff (PDF)

Improvement of insulin response in the streptozotocin model of insulin-dependent diabetes mellitus. Insulin response with and without a long-acting insulin treatment

Animal (Cambridge, England), 2009-05, Vol.3 (5), p.685-689

2009

Volltextzugriff (PDF)

Explicit spreadsheet method for predicting internal corrosion in two galvanically coupled long pipes

Corrosion engineering, science, and technology, 2013-04, Vol.48 (2), p.87-97

2013

Volltextzugriff (PDF)

Ormeloxifene efficiently inhibits ovarian cancer growth

Cancer letters, 2015-01, Vol.356 (2), p.606-612

2015

Volltextzugriff (PDF)

Renal oxygenation and haemodynamics in acute kidney injury and chronic kidney disease

Clinical and experimental pharmacology & physiology, 2013-02, Vol.40 (2), p.138-147

2013

Volltextzugriff (PDF)

Preserving Musicality Through Pictures: A Linguistic Pathway to Conventional Notation

General music today, 2016-10, Vol.30 (1), p.45-52

Nordquist, Alice L.

2016

Volltextzugriff (PDF)

Intradermal Insulin Delivery: A Promising Future for Diabetes Management

Journal of diabetes science and technology, 2014-05, Vol.8 (3), p.453-457

2014

Volltextzugriff (PDF)

Supporting English Language Arts Standards Within the Context of Early Singing Experiences

General music today, 2015-04, Vol.28 (3), p.33-36

Nordquist, Alice L.

2015

Volltextzugriff (PDF)

898TiPThe extended/phase II study of safety and tolerability of proxalutamide (GT0918) in subjects with metastatic castrate resistant prostate cancer (mCRPC) who failed either abiraterone (Abi) or enzalutamide (Enza)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

EP-1618: Monoubiquitinylated histone H2B as a potential target in treatment resistant germ cell tumors

Radiotherapy and oncology, 2018-04, Vol.127, p.S871-S871

2018

Volltextzugriff (PDF)

DNA vaccines: an active immunization strategy for prostate cancer

Seminars in oncology, 2003-10, Vol.30 (5), p.659-666

2003

Volltextzugriff (PDF)

OC-0635 Targeting TEMPRSS2:ERG fusion to achieve a tumor-specific radiosensitization in prostate cancer

Radiotherapy and oncology, 2019-04, Vol.133, p.S338-S339

2019

Volltextzugriff (PDF)

416PDFinal results from a phase i clinical trial evaluating the safety, immunogenicity, and anti-tumor activity of SNS-301 in men with biochemically relapsed prostate cancer

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Safety And Clinical Outcomes Of Radium-223 With Concomitant Radiotherapy Or Subsequent Treatment With The Investigational Agent 177Lu-PSMA In Patients With Metastatic Castration-Resistant Prostate Cancer: An Interim Analysis Of The REASSURE Study

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e854-e855

2020

Volltextzugriff (PDF)

EP-2301: ERG overexpression in PCa drives a switch to the alt-EJ which render cells radiosensitive to PARPi

Radiotherapy and oncology, 2018-04, Vol.127, p.S1270-S1270

2018

Volltextzugriff (PDF)

Phase I study of apalutamide (ARN) plus abiraterone acetate (AA), docetaxel (D) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC)

Annals of oncology, 2017-09, Vol.28, p.v291-v291

2017

Volltextzugriff (PDF)

870PA phase IIa study of radium-223 dichloride (Ra-223) alone or in combination with abiraterone acetate or enzalutamide in metastatic castration-resistant prostate cancer (mCRPC)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Student Preparation for the National Board Dental Hygiene Examination: A national survey of dental hygiene program directors

Journal of dental hygiene, 2017-04, Vol.91 (2), p.23-31

2017

Volltextzugriff (PDF)

1 – 25 von 332

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(273)
Mit Volltextzugriff
(281)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(172)
Life Sciences & Biomedicine
(109)
Humans
(73)
Technology
(55)
Physical Sciences
(48)
Male
(46)
Female
(42)
Animals
(40)
Medicin Och Hälsovetenskap
(37)
Engineering
(36)
Physics
(36)
Biological And Medical Sciences
(29)
Exact Sciences And Technology
(29)
Physics, Applied
(29)
Engineering, Electrical & Electronic
(28)
Medical Sciences
(27)
Applied Sciences
(18)
Medicine
(18)
Oncology
(18)
Psychiatry
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Painless Drug Delivery Through Microneedle-Based Transdermal Patches Featuring Active Infusion

Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases

Final results from a phase i clinical trial evaluating the safety, immunogenicity, and anti-tumor activity of SNS-301 in men with biochemically relapsed prostate cancer

Synthetic DNA immunotherapy in biochemically relapsed prostate cancer

177Lu-PSMA-617 dans le cancer de la prostate métastatique résistant à la castration PSMA positif : analyse des traitements antérieurs et concomitants – VISION

[177Lu]Lu-PSMA-617 dans le cancer de la prostate métastatique positif au PSMA et résistant à la castration : analyses des sous-groupes de traitement antérieurs et concomitants de l’essai vision

A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or in combination with abiraterone acetate/prednisone or enzalutamide

4 Activity of galeterone in castrate-resistant prostate cancer (CRPC) with C-terminal AR loss: Results from ARMOR2

Improvement of insulin response in the streptozotocin model of insulin-dependent diabetes mellitus. Insulin response with and without a long-acting insulin treatment

Explicit spreadsheet method for predicting internal corrosion in two galvanically coupled long pipes

Ormeloxifene efficiently inhibits ovarian cancer growth

Renal oxygenation and haemodynamics in acute kidney injury and chronic kidney disease

Preserving Musicality Through Pictures: A Linguistic Pathway to Conventional Notation

Intradermal Insulin Delivery: A Promising Future for Diabetes Management

Supporting English Language Arts Standards Within the Context of Early Singing Experiences

898TiPThe extended/phase II study of safety and tolerability of proxalutamide (GT0918) in subjects with metastatic castrate resistant prostate cancer (mCRPC) who failed either abiraterone (Abi) or enzalutamide (Enza)

EP-1618: Monoubiquitinylated histone H2B as a potential target in treatment resistant germ cell tumors

DNA vaccines: an active immunization strategy for prostate cancer

OC-0635 Targeting TEMPRSS2:ERG fusion to achieve a tumor-specific radiosensitization in prostate cancer

416PDFinal results from a phase i clinical trial evaluating the safety, immunogenicity, and anti-tumor activity of SNS-301 in men with biochemically relapsed prostate cancer

Safety And Clinical Outcomes Of Radium-223 With Concomitant Radiotherapy Or Subsequent Treatment With The Investigational Agent 177Lu-PSMA In Patients With Metastatic Castration-Resistant Prostate Cancer: An Interim Analysis Of The REASSURE Study

EP-2301: ERG overexpression in PCa drives a switch to the alt-EJ which render cells radiosensitive to PARPi

Phase I study of apalutamide (ARN) plus abiraterone acetate (AA), docetaxel (D) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC)

870PA phase IIa study of radium-223 dichloride (Ra-223) alone or in combination with abiraterone acetate or enzalutamide in metastatic castration-resistant prostate cancer (mCRPC)

Student Preparation for the National Board Dental Hygiene Examination: A national survey of dental hygiene program directors

Suchergebnisse filtern